TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
INKT

Mink Therapeutics Inc

Healthcare · Biotechnology

12.30$ +1.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement INKT
Line item 2019 2020 2021 2022 2023 2024 2025
– -100.0% – – -100.0% – –
– – +41.6% +56.2% +68.1% +5.3% -15.6%
– -108.0% – – – – –
– -51.6% +46.9% +65.5% -33.0% -59.1% +90,768.4%
– -66.4% +260.3% +68.8% -5.1% +57,955.5% +56.0%
– -53.2% +72.5% +66.4% -26.3% -54.1% +17.9%
– – – – – – –
– +56.4% -0.4% -89.6% – – –
– – – – – – –
– -126.5% – – – -359,133,906,700.0% –
– – – – – – –
– – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?